Mid
T
TARSAI Stock Diagnostic Report
Tarsus buys iRenix Medical for $75M, gains late-stage eye care asset IRX-101
[MISTRAL] Tarsus has acquired ophthalmic medical assets, including IRX-101, for $75 million, strengthening its competitiveness in the eye care sector.
View Source Article ↗AI CATALYST SCORE70 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time